Literature DB >> 30632070

Potential role of serum fetuin-A in relation with pro-inflammatory, chemokine and adhesion molecules in diabetic kidney disease: a case-control study.

Shaik Sarfaraz Nawaz1, Salini Scaria Joy1, Yousuf Al Farsi2, Teena P George1, Khalid Siddiqui3.   

Abstract

Inflammatory cytokine, adipokine and adhesion molecules are known to play a key role in pathogenesis of diabetic kidney disease (DKD). In this study, our aim was to investigate the role of fetuin-A in relation with pro-inflammatory cytokines (IL-6, IL-18), adipokines (adiponectin, leptin), chemokine (MCP-1), and adhesion molecules (ICAM-1, VCAM-1) in control and DKD subjects. We recruited a total of 224 type 2 diabetic (T2D) subjects. The control subjects were T2D with a normal albumin excrete (albumin-to-creatinine ratio-ACR ≤ 30 mg/g creatinine) and estimated glomerular filtration rate (eGFR) ≥ 60 (ml/min/1.73 m2), while cases were T2D subjects with albumin excrete (ACR ≥ 30 mg/g creatinine) and eGFR ≤ 60 (ml/min/1.73 m2). FBS, HbA1c, lipid profile (TC, LDL, HDL, triglyceride), ALT, AST, GGT, serum creatinine, BMI, blood pressure was evaluated in all the study subjects. Randox evidence biochip analyzer was used for measuring inflammatory cytokines, adipokines, and adhesion molecules by chemiluminescent assay. Serum fetuin-A and IL-18 were measured by ELISA kits. Serum fetuin-A levels were significantly decreased in DKD cases compare to control group [456.8 (299.2-649.0) µg/ml versus 670.6 (573.0-726.1) µg/ml; p < 0.001)]. Serum fetuin-A levels correlates significantly with IL-6, IL-18, TNF-α, PAI-1, leptin, resistin and ACR (p < 0.001). This study concludes that serum fetuin-A and pro-inflammatory markers (IL-18, IL-6, IL-1α and TNF-α) might play an important role in the pathophysiology and inflammatory process of DKD.

Entities:  

Keywords:  DKD; Fetuin-A; IL-18; IL-6; T2D ICAM-1; VCAM-1

Mesh:

Substances:

Year:  2019        PMID: 30632070     DOI: 10.1007/s11033-019-04592-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  5 in total

Review 1.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

2.  Identification of potential salivary biomarker panels for oral squamous cell carcinoma.

Authors:  Anu Jain; Chinmaya Narayana Kotimoole; Sushmita Ghoshal; Jaimanti Bakshi; Aditi Chatterjee; Thottethodi Subrahmanya Keshava Prasad; Arnab Pal
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

Review 3.  Accelerated Kidney Aging in Diabetes Mellitus.

Authors:  Jing Guo; Hui Juan Zheng; Wenting Zhang; Wenjiao Lou; Chenhui Xia; Xue Ting Han; Wei Jun Huang; Fan Zhang; Yaoxian Wang; Wei Jing Liu
Journal:  Oxid Med Cell Longev       Date:  2020-07-27       Impact factor: 6.543

Review 4.  MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

Authors:  Hong Zhou; Wei-Jian Ni; Xiao-Ming Meng; Li-Qin Tang
Journal:  Front Cell Dev Biol       Date:  2021-01-25

5.  Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins.

Authors:  Jack Jingyuan Zheng; Joanne K Agus; Brian V Hong; Xinyu Tang; Christopher H Rhodes; Hannah E Houts; Chenghao Zhu; Jea Woo Kang; Maurice Wong; Yixuan Xie; Carlito B Lebrilla; Emily Mallick; Kenneth W Witwer; Angela M Zivkovic
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.